24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Exalenz
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
18:45
Meta got off easy, but the settlement it reached could be a game-changer
18:44
Orca: “The attack surface is evolving faster than the security models around it”
16:58
Court appoints administrator for Papaya Gaming, demands stronger debt plan
16:41
Meta in talks to settle addiction lawsuit, fine could reach $1.4 trillion
More stories
Buzz
Most popular
Daily
Weekly
1
Alice raises $140 million at $700-800 million valuation after betting that AI will need a new security layer
2
After raising $51 million, Minimus shuts down as Twistlock founders return remaining cash to investors
3
The 50 most promising Israeli startups - 2026
4
Mossad, Shin Bet lead the pack: Inside Israel's security sector salary report
5
Sam Altman admits he underestimated how slowly the economy would embrace AI
More news
Exalenz
2 stories about Exalenz
Exalenz Bioscience Acquired for $49M
19.02.20
|
Golan Hazani
Israeli-born billionaire & biomed entrepreneur Mori Arkin sold his company for 6.10 NIS per share. Learn more on CTech!
Biomed Entrepreneur Mori Arkin Nearing Sale of Exalenz to a U.S. Company
19.02.20
|
Golan Hazani
Tel Aviv-listed Exalenz is not considered one of the serial entrepreneur’s great successes, having lost 73% of its valuation over the past five years. The current deal will see it sold at a premium of tens of percentages, according to one source